Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.
Journal: JCO oncology practice
Published: June 23, 2026
Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.
Journal: Cancers
Published: November 27, 2025
Molecularly Targeted Cancer Medications and Kidney Health.
Journal: JAMA network open
Published: November 06, 2025
Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management.
Journal: Journal of the American Academy of Dermatology
Published: June 30, 2025
Clinical Improvement of Treatment-Resistant Metastatic Basal Cell Carcinoma After Intratumoral Injection of Talimogene Laherparepvec.
Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
Published: March 03, 2025
An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma.
Journal: Annals of surgical oncology
Published: January 02, 2025
The association between metformin use, immune mediated colitis and overall survival in patients treated with checkpoint inhibitor.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 10, 2024
Subgroup analyses of the phase 3 FOCUS study of melphalan/hepatic delivery system in patients with unresectable metastatic uveal melanoma.
Journal: Journal of cancer research and clinical oncology
Published: November 22, 2024
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: November 13, 2024
Cardiac Troponin Screening and Clinical Outcomes in Patients Receiving Immunotherapy.
Journal: JACC. CardioOncology
Published: August 15, 2024
Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 25, 2024
Last Updated: 09/26/2026